Our study firstly finds that DHX9 expression is significantly increased in oxLDL or interferon-γ-treated macrophages and peripheral blood mononuclear cells (PBMCs) from patients with coronary artery disease (CAD). The gene discussed is DHX9; the disease is coronary artery disorder.